Forty patients (47 eyes) with open-angle glaucoma who had been treated by laser trabeculoplasty to help reduce intraocular pressure were reviewed. The majority of patients had been followed for at least one year. Eighty-nine percent responded satisfactorily, with an average pressure decrease of 5 mmHg. There was no evidence of decay (pressure reversal) after one year. Seventy-six percent of patients who had been on carbonic anhydrase inhibitor medication were able to discontinue this therapy after laser treatment. Blacks, aphakic and diabetic patients responded satisfactorily, but hypertensive patients and those with narrow-angle glaucoma less so. Re-lasering was successful in only one of 6 patients.
Introduction
We recently published a study entitled 'Argon laser trabecular surgery as an alternative to carbonic anhydrase therapy' (Fink et al. 1982) , the rationale for which stemmed from numerous reports in the literature (Epstein & Grant 1977 , Berson & Epstein 1980 , Lichter 1981 ) describing many undesirable side effects and poor compliance associated with carbonic anhydrase inhibitor (CAI) medications. Ninety-four percent of our patients -responded well to laser trabeculoplasty, with an average pressure decrease of 9.9 mmHg. These patients have subsequently been followed (at least every three months) and many new patients have been added to the study. A number of recent reports have noted a gradual rise in intraocular pressure in patients treated successfully with laser trabeculoplasty (Schwartz & Kopelman 1983 , Pollack & Robin 1983 . The purpose of the present study was to determine if, and to what extent, such a pressure decay was present in our patients. We also examined the effect of diabetes, hypertension, race, age, and number of burns on the success of laser trabeculoplasty.
Methods
All patients studied were diagnosed as having open-angle glaucoma. There were two groups of patients: those who were on carbonic anhydrase inhibitor (CAI) therapy which was discontinued two weeks before laser treatment; and those not on CAI therapy but whose lack of pressure control on maximally-tolerated topical medication demanded CAI or laser treatment.
The intraocular pressure was measured two weeks and one week before laser treatment.
Comeal endothelial cell photography was not continued because our previous study (Fink et al. 1982) failed to demonstrate a significant change in the number or morphological characteristics of these cells after laser treatment. Post-laser intraocular pressure and visual acuity were recorded and slit-lamp examination performed the day after treatment. Examinations were repeated weekly for one month and the recordings were then made biweekly for one month and then monthly.
A continuous-wave Argon laser (Coherent Radiation Model 800) capable of 3-W output was used throughout the study. The eye was anaesthetized with 0.5% topical proparacaine hydrochloride. A single mirror gonioprism was applied to the cornea and the trabecular meshwork was visualized at twenty-five times magnification. The method of treatment adopted for the first 25 patients was similar to that described by Wise & Witter (1979) . One hundred 50 i burns with a power that varied between 1.0 and 1.3-W were applied for 0.1 seconds and directed at the midtrabecular meshwork. We sought to limit post-laser pressure rise in the last 17 patients by (a) choosing the anterior or midtrabecular region for treatment; (b) reducing the number of burns to the sixties range; (c) reducing the power to 900 mV; and (d) using trabecular blanching (rather than bubble formation) as a preferred response to laser energy. All patients continued their pre-laser medication and in addition were given gentamicin and fluorometholone (FML) drops to be used four times daily in the treated eye. The latter two medications were discontinued (usually within the first week) when reaction had subsided.
The data were analysed using a North Star Horizon 64K microcomputer with a 5 megabyte hard disk capacity, and were stored on a data base management system; mean, standard error and t tests were computed using a standard microcomputer statistical program (Northwest Analytical Stat-Pack). The data are expressed as the average intraocular pressure±standard error of the mean. A baseline pressure is defined as the average intraocular pressure on preoperative medical therapy. Post-laser pressure is the average intraocular pressure (IOP) on maximally tolerated drops after laser therapy.
Results
Forty-nine eyes (42 patients) were treated. Two patients were ultimately excluded because their intraocular pressures and response to laser therapy were significantly different from the remaining population. There was a wide swing between the pre-laser pressure (50-60 mmHg) and post-laser pressure (14-16 mmHg) in these two patients which returned to baseline within six months. This kind of decay (reversal) has been described ).
The finalized data were obtained, therefore, from 40 patients (47 eyes) on whom 53 laser trabeculoplasty procedures had been performed. Forty-two eyes responded satisfactorily to trabeculoplasty, providing an overall success rate of 89%. For all patients, the average IOP pretreatment was 25+0.3 mmHg and at one year post-laser therapy was 20 ± 0.3 mmHg, the difference being statistically significant (P <0.05). There were 5 failures. In the 29 untreated eyes (4 patients had either only one eye or one blind eye) there was a measurable drop in IOP of up to 10 mmHg in many patients, but this had returned to baseline within 3 months; their average IOP pre-and one year post-laser was 24 + 0.3 mmHg. The difference in IOP between treated and untreated eyes one year post-laser was significant (P <0.05). There was no evidence of post-laser pressure rise in the treated eye within the first year (Table 1) .
Sixteen (76%) of 21 patients who were on CAI drugs, which were discontinued two weeks before laser therapy, responded favourably and were able to continue without this medication. Their IOP, which averaged 24 + 0.3 mmHg pre-laser, dropped to 19 + 0.46 mmHg after treatment. The 19 patients who had not been on CAI therapy averaged an IOP drop of 6 mmHg post-laser, from 25 ±0.73 to 19 ±0.49 mmHg. Four patients (5 eyes) who were previously diagnosed as narrow-angle glaucoma and had undergone laser iridotomy (2 eyes) or surgical iridectomy (I eyes) responded to laser trabeculoplasty with an average 3 mmHg pressure drop, from 24±0.92 to 21 ±0.77 mmHg. Our experience with re-lasering was disappointing. Six patients with open-angle glaucoma, 5 of whom had been on CAI drugs, were re-lasered when their IOP failed to drop substantially after initial laser trabecular surgery. Only one responded satisfactorily.
The pressure drop following laser trabecular surgery in the older patients was compared with the response in the younger ones. The median age was 74 years (range 45-87). The pressure drop averaged 6 mmHg in the younger patients and 4 mmHg in the older ones. This difference in intraocular pressure drop was not statistically significant (P >0.05).
An attempt was made to determine the influence of the number of burns on intraocular pressure. Patients were divided into two groups according to whether they had received more or less than 70 burns. There was no significant difference in the pressure response to laser treatment in these two groups. The satisfactory response of' 5 black and 7 aphakic patients to trabeculoplasty is consistent with previous reports (Fink et al. 1982 , Schwartz et al. 1981 . Five hypertensive patients demonstrated a 2 mmHg average drop in intraocular pressure. The significance of this poor response could not be analysed due to the small number of patients (Table 2) .
Post-laser reaction was minimal. There was some mild to moderate conjunctival injection in 20% of patients, which lasted up to one week. Uveal response (beam and cells in anterior chamber) was absent in our cases. No systemic complications were noted. Superficial burns on the corneal epithelium (a result of reflected energy), noted in one-third of patients, healed within three days without scarring.
Discussion
Argon laser trabeculoplasty continues to be effective in helping to control the intraocular pressure in glaucoma patients, and with its lack of complications it may be considered as an effective alternative to CAI drugs and surgery. Our overall success rate of 89% compares favourably with other reports (Thomas et al. 1982) . Follow-up time varied from three to eighteen months, the majority of patients being studied for more than one year after treatment.
Decay effect (pressure reversal) after trabeculoplasty was first recognized in patients with pre-laser pressure readings above 35 mmHg , Wilensky 1983 ). There were two such patients in this series, and they were eliminated from the study because the pressure swings and reversals were so inconsistent with the remaining patient population. More recently, there have been a number of reports indicating a small decay effect in patients treated (Schwartz & Kopelman 1983 , Pollack & Robin 1983 ). An analysis of all of our patients revealed that the post-laser pressure decrease of 5 mmHg was essentially unchanged after one year. A 1 mmHg decay noted in the 18-24 month period was seen in the few patients followed for longer than eighteen months. We are not certain that this is a significant finding. Wilensky & Weinreb (1983) recently noted no decay effect after one year in their series of 52 patients.
In our previous study (Fink et al. 1982) it was suggested that laser trabeculoplasty was a desirable alternative to carbonic anhydrase inhibitor therapy, and in the present study 76% (16/21) of patients on CAI drugs responded favourably to laser trabeculoplasty as an alternative to these medications, with an average pressure decrease of 5 mmHg. The use of lasers to help avoid the undesirable side effects and poor compliance attributed to CAI drugs continues to be justified (Pollack & Robin 1982) . Laser therapy in conjunction with CAI drugs normalized the intraocular pressure of 5 patients who had failed to respond to trabeculoplasty or to CAI medications.
Although our previous report showed an average post-laser pressure decrease of 9.9 mmHg, this is reduced to 5.0 mmHg in this present study. This would seem to indicate post-laser pressure decay (reversal), but the difference can be explained by the different parameters used in each study. The major difference involved the large number of patients on CAI medications. Our present study used on-CAI drugs as pretreatment pressure (24 mmHg) while our previous study recorded off-CAI medication as pretreatment pressure (29.5 mmHg). Wilensky (1983) also noted an average decrease of 5 mmHg.
An average 4.2mmHg drop in the contralateral (untreated) eye noted previously by ourselves is not confirmed in this study. Although some patients did have a temporary contralateral pressure drop (up to 10 mmHg), the pressure returned to its pretreatment level within three months. However, even if temporary, it is still curious that lasering one eye may disturb the homeostasis of the untreated eye to produce a temporary pressure-lowering effect.
Post-laser pressure rise has been of considerable concern to ophthalmologists (Pohjanpelto 1981, Thomas et al. 1982) . Some patients with advanced glaucoma have required filtering surgery within two weeks after laser treatment to prevent a severe loss of vision (Schwartz & Kopelman 1983) . Recent information indicates that significant elevations of the intraocular pressure may occur within the first 10 hours after laser treatment ). Although we did not measure pressure within the first 24 hours, a pressure rise was recorded in 25% of patients treated successfully. This laser-induced ocular hypertension normalized within three weeks. A considerable reduction in post-laser pressure rise has been achieved by adjusting our technique, and such changes have included:
(1) reducing the number of burns from 100 to the sixties range at 360° (Wilensky 1983 , Weinreb et al. 1983a ); (2) directing the laser energy at the midor anterior trabecular meshwork ); (3) reducing the power from the 1.0 to the 1.3-W range to 900 m V (Wilensky 1983) ; (4) using blanching rather than small bubble formation as the end point.
Our most recent patients are being lasered satisfactorily with 40-50 burns at 1800 (Thomas et al. 1982 , Weinreb et al. 1983b ). Patients who received less than 70 burns at 900 mV power responded with a pressure decrease similar to those who received more than 70 burns at 1.0 to 1.3-W and with a smaller post-laser pressure rise.
The response to laser trabeculoplasty of 4 patients (5 eyes) with a previous history of angle closure glaucoma was interesting. Each eye had undergone previous laser iridotomy or surgical iridectomy. As also reported elsewhere (Thomas et al. 1982) , the results were moderately successful.
The advisability of re-lasering patients after an initial success is questionable. Certainly the findings of Gaasterland & Kupfer (1974) , who induced glaucoma in a Rhesus monkey by excessive lasering of the trabecular meshwork, would advise against such treatment. Wise (1983) presents some evidence for re-lasering in selective cases, but others do not agree (Wilensky 1983 , Beckman 1983 . In our series, only one of 6 patients who were re-lasered responded satisfactorily.
Some authors have suggested that older patients exhibit greater and more predictable post-laser pressure drops when compared with a younger population (Schwartz & Kopelman 1983) . The most accepted explanation for such an observation stems from Wise's hypothesis that trabeculoplasty induces a small degree of scarring with circular contraction of the trabecular meshwork, thus contributing to opening the intertrabecular spaces with a measurable increase in aqueous outflow (Wise & Witter 1979) . This concept is in agreement with the work of others who have suggested that the trabecular wall stretches with age (Nesterov 1970 , Nesterov & Batmanov 1974 , Ellingson & Grant 1971 , Johnstone & Grant 1973 , Grierson & Lee 1974 . In our study the difference in the pre-and post-laser response between those under and over 74 years of age was not statistically significant. However, few of the patients were really 'young', and there was an abundance of patients in the older age group. It is of interest, though, that our younger patients showed a greater (albeit insignificant) intraocular pressure-lowering effect. It may be that their disease was less advanced and thus responded better to laser therapy.
Black patients and aphakic patients, as previously reported, continued to respond well to trabeculoplasty (Schwartz & Kopelman 1983 , Fink et al. 1982 . Diabetic patients also demonstrated a very satisfactory response. It is gratifying to note that black, aphakic, and diabetic patients who respond poorly to surgical trabeculoplasty will respond satisfactorily to laser treatment. We are unsure why our hypertensive patients responded so poorly. The mean decrease in intraocular pressure of only 2 mmHg was disappointing. However, only 5 patients (7 eyes) in this series were hypertensive. It may be that a healthy peripheral circulation contributes to the success of trabeculoplasty.
Although laser trabeculoplasty may not be as successful as trabeculectomy (Wilensky 1983) , it avoids the many complications attributable to filtering surgery (Watson & Grierson 1981 , Simmons 1983 . The risk/benefit ratio warrants the use of trabeculoplasty as an alternative to CAI drugs and surgery (Fink et al. 1982) . Despite the enthusiasm of many ophthalmologists for the long-term effects of this procedure (Wise 1983 , Wilensky 1983 , Worthen 1983 , reports have emerged suggesting the possibility of pressure decay (reversal) . Only time with careful observation will determine whether these patients will continue to benefit from this new therapy. Laser trabeculoplasty may have induced permanent structural changes in the trabecular meshwork that may result in failure. However, even with decay, laser trabeculoplasty has deferred the sight-threatening risks and the cataractogenic effects of filtering surgery.
